Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992 Jun;17(2):68-71.

[Use of low doses of bromocriptine in chronic schizophrenia resistant to neuroleptics. A preliminary study]

[Article in French]
M A Wolf  1 , J M Diener, C Lajeunesse, C Shriqui
Affiliations
Clinical Trial

[Use of low doses of bromocriptine in chronic schizophrenia resistant to neuroleptics. A preliminary study]

[Article in French]
M A Wolf et al. J Psychiatry Neurosci. 1992 Jun.

Abstract

In this work, we report the efficiency of bromocriptine (1.25 and 2.5 mg/day) in 9 neuroleptic resistant chronic schizophrenics. Following an initial four-week placebo period, the subjects successively received bromocriptine (1.25 mg/day), placebo and bromocriptine (2.5 mg/day). The 2 bromocriptine treatments significantly improved the global psychiatric symptomatology and different scores and factors related to the more specific schizophrenic symptomatology. An escape phenomenon seems to occur during the 4th week of the first bromocriptine treatment (1.25 mg/day) but is not observed with the second treatment (2.5 mg/day). All patients improved.

PubMed Disclaimer

References

    1. Psychiatr J Univ Ott. 1989 Nov;14(4):529-35 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(3):279-87 - PubMed
    1. Science. 1979 Oct 5;206(4414):80-2 - PubMed
    1. Psychopharmacology (Berl). 1983;81(1):37-41 - PubMed
    1. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(2):277-83 - PubMed

LinkOut - more resources